RANI Rani Therapeutics Holdings, Inc.
Healthcare$0.97+0.00%OpenMarket Cap: $63.2M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
6.78
P/S
22.05
EV/EBITDA
-1.90
DCF Value
$0.34
FCF Yield
-24.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
94.9%
Operating Margin
-1093.0%
Net Margin
-929.1%
ROE
-245.5%
ROA
-56.8%
ROIC
-87.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $1.7M | 90.6% | $-8.3M | $-7.0M | $— | — |
| Q4 null | $1.5M | 100.0% | $-8.5M | $-10.3M | $— | — |
| FY null | $1.6M | 44.9% | $-38.3M | $-29.7M | $— | — |
| Q3 null | $0.00 | NaN% | $-7.3M | $-5.4M | $— | — |
| Q2 null | $0.00 | NaN% | $-10.5M | $-6.7M | $— | — |
| Q1 null | $172.0K | 100.0% | $-12.0M | $-7.3M | $— | — |
| Q4 null | $1.0M | 100.0% | $-15.0M | $-8.9M | $— | — |
| FY null | $1.0M | 100.0% | $-53.3M | $-30.0M | $— | — |
| Q3 null | $0.00 | NaN% | $-11.8M | $-6.8M | $— | — |
| Q2 null | $0.00 | NaN% | $-12.5M | $-6.8M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-14.0M | $-7.5M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-13.4M | $-7.1M | $-0.27 | — |